Navigation Links
BioElectronics and YesDTC Holdings Receive Japanese Regulatory Review Date
Date:7/27/2010

FREDERICK, Md., July 27 /PRNewswire-FirstCall/ -- BioElectronics Corp. (Pink Sheets: BIEL), manufacturers of innovative pain relieving medical devices, today announced its distribution partner for Japan, YesDTC Holdings, Inc. (OTC Bulletin Board: YESD) has received notification from its legal staff of the pending review by Japanese government medical device regulators for the ActiPatch™ and Allay™ Menstrual Relief products.  This review will take place on Wednesday, July 28th.

The initial analysis by YesDTC's attorneys has been very favorable toward the Company's ability to begin marketing in Japan as several similar devices are already on the market.  This regulatory review is designed to verify that Japanese regulatory agencies will place ActiPatch and Allay in the same category as these currently marketed devices or if additional information and or testing will be required.  

BioElectronics and YesDTC recently announced several important product line enhancements specifically tailored to suit the needs of the highly discerning and quality conscious Japanese marketplace.  Additionally, upon release, BioElectronics will make the recently announced back pain belt available to the Japanese marketplace.

Andrew Whelan, CEO of BioElectronics, commented, "We view the Japanese market as being significant to our future success.  There is a history of Japanese regulators closely mirroring the medical device classifications that had earlier occurred within the European Union, where we are a Class IIa device.  This pending review, which will take place this week, should offer us a great deal of information about the timing in what we believe will be a highly profitable market."

About BioElectronics Corporation

BioElectronics Corporation is the maker of ActiPatch® Therapy, RecoveryRx(TM) Devices, HealFast(TM) Therapy (www.healfasttherapy.com) and the Allay(TM) family of inexpensive, disposable drug-free anti-inflammatory devices. For more information please see http://www.bielcorp.com.


'/>"/>
SOURCE BioElectronics Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BioElectronics Announces Profitability Breakeven and Additional Clinical Trials
2. BioElectronics Announces Major Clinical Trials
3. CardioGenics Holdings Inc. Receives New Ticker Symbol
4. Zimmer Holdings to Present at BMO Capital Markets Tenth Annual Focus on Healthcare Conference
5. Mastech Holdings, Inc. to Discuss Second Quarter 2010 Financial Results on July 28, 2010
6. RoundTable Healthcare Partners Announces Sale of Bioniche Pharma Holdings Limited to Mylan Inc.
7. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Second Quarter 2010 Results
8. Bacterin International Holdings, Inc. Completes Merger and $7.5 Million Raise
9. Compass Diversified Holdings to Host Investor and Analyst Event on June 10, 2010
10. China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010
11. Zimmer Holdings to Present at Bairds 2010 Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... Denmark , Oct. 2, 2017 The Rebound ... in the struggle to reverse the tide of prescription drug ... for regulating their medicine intake and stepping down their dosage ... set to launch in December 2017; the first 100,000 people ... Learn more at http://www.rebound-solution.com/ ...
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
Breaking Medicine Technology:
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards luncheon ... editorial and design excellence across a range of sectors. This year’s program included the ...
Breaking Medicine News(10 mins):